COVID-19 Pandemic (Coronavirus)
- Thread starter null
- Start date
StretfordRed
Afro-European
Oxford University
Edit* that’s a terrible article. Take the BBC one instead
Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK
Glad this is come. 12 weeks between shots and can be stored in a normal fridge. It doesn’t use mRNA as far as I can tell:
May need that 95%
Last edited:
DaRealness
I think very deeply
Yahoo is now a part of Verizon Media
Saleha Riaz
Wed, 30 December 2020, 8:22 am GMT·4-min read
The UK government has said the NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. Photo: Getty
The UK said on Wednesday it will authorise the Oxford University/AstraZeneca’s COVID-19 vaccine for use in the country. AstraZeneca’s (AZN.L) shares were up roughly 3.3% Wednesday morning.
Heath secretary Matt Hancock hailed this as “a great success story” on BBC Radio 4 and said “the government can now accelerate its delivery plan so we we can bring this pandemic to an end faster than we previously would have been able to. The vaccine is our way out of this.”
“I hope we can be out of this by the spring,” he added.
The government has said the decision to approve the vaccine “follows rigorous clinical trials and a thorough analysis of the data by experts at the Medicines and Healthcare products Regulatory Agency (MHRA), which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness.”
It aso said the NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. It has already vaccinated hundreds of thousands of patients with the Pfizer (PFE) /BioNTech (BNTX) vaccine.
The government’s Joint Committee on Vaccination and Immunisation has advised that priority should be to give as many people in at-risk groups their first dose, rather than providing the required two doses in as short a time as possible.
WATCH: UK hails ‘significant moment’ as Oxford COVID-19 vaccine given green light
Scroll back up to restore default view.
Everyone will still receive their second dose and this will be within 12 weeks of their first. The second dose completes the course and is important for longer term protection, the Department of Health and Social Care explained.
“With two vaccines now approved, we will be able to vaccinate a greater number of people who are at highest risk, protecting them from the disease and reducing mortality and hospitalisation,” it said.
It was reported earlier that mass vaccination centres at conference venues and sports stadiums are primed to launch in the second week of next month, provided MHRA approves the vaccine.
The NHS is to give top priority to vaccinating those aged 80 and above. Frontline healthcare workers, care home staff and residents will also be among those first in line.
NHS calculations suggest up to 46,000 staff would be needed to deliver the vaccination programme, assuming a 75% take-up rate.
The UK government has ordered 100 million jabs of the Oxford vaccine, with 40 million due to be rolled out by March next year.
Over the weekend, Pascal Soriot, the chief executive of AstraZeneca, said that its vaccine is as effective as the ones developed by Pfizer and Moderna (MRNA).
The UK recorded 210 COVID-19 deaths on Saturday, down from 570 the day before, while cases rose 1,968 to 34,693, the government said.
The UK has recorded a total death toll of 70,405 over the weekend, defined as those dying within 28 days of a positive test. Under this measure, it is the world’s sixth largest toll, after the United States, Brazil, India, Mexico and Italy.
READ MORE: UK to spend £11.7bn on vaccine rollout and take liability for drug firms
The latest R number in Britain is estimated at 1.1 to 1.3.
A report from earlier this month showed that the government will spend up to £11.7bn ($15.8bn) on securing vaccines for the UK and rolling them out in England, as well as potentially covering drugmakers’ costs if they face legal action.
Meanwhile, the UK economy has been ravaged by the pandemic this year — GDP has fallen by historic amounts, unemployment has soared, and government debt has reached its highest point in post-war history. Companies have been forced into painful restructurings and entire industries have faced unprecedented disruption.
Earlier this month, UK prime minister Boris Johnson dramatically cancelled Christmas for millions across London and the South East amid fears a new strain of the virus is taking hold and spreading more rapidly.
Non-essential shops, gyms, cinemas, hairdressers and bowling alleys will be forced to close, he had said, dealing another blow to the hospitality industry.
Saleha Riaz
Wed, 30 December 2020, 8:22 am GMT·4-min read
The UK government has said the NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. Photo: Getty
The UK said on Wednesday it will authorise the Oxford University/AstraZeneca’s COVID-19 vaccine for use in the country. AstraZeneca’s (AZN.L) shares were up roughly 3.3% Wednesday morning.
Heath secretary Matt Hancock hailed this as “a great success story” on BBC Radio 4 and said “the government can now accelerate its delivery plan so we we can bring this pandemic to an end faster than we previously would have been able to. The vaccine is our way out of this.”
“I hope we can be out of this by the spring,” he added.
The government has said the decision to approve the vaccine “follows rigorous clinical trials and a thorough analysis of the data by experts at the Medicines and Healthcare products Regulatory Agency (MHRA), which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness.”
It aso said the NHS has a clear vaccine delivery plan and decades of experience in delivering large scale vaccination programmes. It has already vaccinated hundreds of thousands of patients with the Pfizer (PFE) /BioNTech (BNTX) vaccine.
The government’s Joint Committee on Vaccination and Immunisation has advised that priority should be to give as many people in at-risk groups their first dose, rather than providing the required two doses in as short a time as possible.
WATCH: UK hails ‘significant moment’ as Oxford COVID-19 vaccine given green light
Scroll back up to restore default view.
Everyone will still receive their second dose and this will be within 12 weeks of their first. The second dose completes the course and is important for longer term protection, the Department of Health and Social Care explained.
“With two vaccines now approved, we will be able to vaccinate a greater number of people who are at highest risk, protecting them from the disease and reducing mortality and hospitalisation,” it said.
It was reported earlier that mass vaccination centres at conference venues and sports stadiums are primed to launch in the second week of next month, provided MHRA approves the vaccine.
The NHS is to give top priority to vaccinating those aged 80 and above. Frontline healthcare workers, care home staff and residents will also be among those first in line.
NHS calculations suggest up to 46,000 staff would be needed to deliver the vaccination programme, assuming a 75% take-up rate.
The UK government has ordered 100 million jabs of the Oxford vaccine, with 40 million due to be rolled out by March next year.
Over the weekend, Pascal Soriot, the chief executive of AstraZeneca, said that its vaccine is as effective as the ones developed by Pfizer and Moderna (MRNA).
The UK recorded 210 COVID-19 deaths on Saturday, down from 570 the day before, while cases rose 1,968 to 34,693, the government said.
The UK has recorded a total death toll of 70,405 over the weekend, defined as those dying within 28 days of a positive test. Under this measure, it is the world’s sixth largest toll, after the United States, Brazil, India, Mexico and Italy.
READ MORE: UK to spend £11.7bn on vaccine rollout and take liability for drug firms
The latest R number in Britain is estimated at 1.1 to 1.3.
A report from earlier this month showed that the government will spend up to £11.7bn ($15.8bn) on securing vaccines for the UK and rolling them out in England, as well as potentially covering drugmakers’ costs if they face legal action.
Meanwhile, the UK economy has been ravaged by the pandemic this year — GDP has fallen by historic amounts, unemployment has soared, and government debt has reached its highest point in post-war history. Companies have been forced into painful restructurings and entire industries have faced unprecedented disruption.
Earlier this month, UK prime minister Boris Johnson dramatically cancelled Christmas for millions across London and the South East amid fears a new strain of the virus is taking hold and spreading more rapidly.
Non-essential shops, gyms, cinemas, hairdressers and bowling alleys will be forced to close, he had said, dealing another blow to the hospitality industry.
CreepyMcCreeperson
Veteran
$cam-U-Well_Jack$on
Superstar
There's no such thing as "normal" anymore. Y'all need to get that notion outta your heads. Any normalcy is gone...for good.
Poling said Biden would win by double digits. He didn't.
It could easily approach 164 million. Maybe 210 million of the population is over 18. 84 million of those is about 40%. If they aren't taking it their children aren't taking it so we're in the ballpark of 130 million not being vaccinated. That's approaching half the population.
Eastside Get The Money
Veteran
He just got elected and was set to be inaugurated in January 3rd
tested positive 11 days ago
Darwinism was a popular drink in my day and still is
So people having to walk around with masks is going to be a permanent thing. Arenas & stadiums only allowing a small percentage of attendees is permanent?
I mean there will be a normal again but it's probably not going to be what we were used to.
Vandelay
Waxing Intellectual
Melatonin is shown to help with prevention and treatment apparently.
Scientists study melatonin as possible COVID-19 treatment
Scientists study melatonin as possible COVID-19 treatment
honestly i think masks are here to stay for some situations when traveling or using public transport etc and for older people. Masks have already been a staple in asian countries for years
Mask should be here to stay especially when you're sick with anything like a cold or the flu. For some reason in this country when people get sick we never wear masks but we should.
That was because of the air quality
Majestyx
Duck Season
in china, it was for air and disease. Japan/korea disease and fashion
